Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 12:06:09 GMT 2023
by
admin
on
Sat Dec 16 12:06:09 GMT 2023
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
RWA84PTK5G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
RWA84PTK5G
Created by
admin on Sat Dec 16 12:06:10 GMT 2023 , Edited by admin on Sat Dec 16 12:06:10 GMT 2023
|
PRIMARY | |||
|
Q9UQL6
Created by
admin on Sat Dec 16 12:06:10 GMT 2023 , Edited by admin on Sat Dec 16 12:06:10 GMT 2023
|
PRIMARY | |||
|
Histone deacetylase 5
Created by
admin on Sat Dec 16 12:06:10 GMT 2023 , Edited by admin on Sat Dec 16 12:06:10 GMT 2023
|
PRIMARY | |||
|
Q9UQL6
Created by
admin on Sat Dec 16 12:06:10 GMT 2023 , Edited by admin on Sat Dec 16 12:06:10 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
WEAK INHIBITOR->TARGET |
BINDING
IC50
|
||
|
INHIBITOR -> TARGET |
IC50
|
||
|
NON-INHIBITOR->TARGET |
Mocetinostat (MGCD0103) is a potent HDAC inhibitor but had no activity to HDAC5. Phase 2.
INHIBITOR
NOT CLINICALLY SIGNIFICANT
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT | CHEMICAL |
|